The Patterns of Treatment Modality and Survival Outcome in Patients with Hepatocellular Carcinoma Accompanying Portal Vein Invasion in Korea: A Multicenter Prospective Cohort Study

被引:0
|
作者
Paik, Yong-Han [1 ]
Sinn, Dong Hyun [2 ]
Lee, Hye Won [3 ]
Kim, Do Young [4 ]
Kim, Yoon Jun [5 ,6 ]
Kim, Kang Mo [7 ]
Bae, Si Hyun [8 ]
Kim, Ji Hoon [9 ]
Seo, Yeon Seok [10 ]
Jang, Jae Young [11 ]
Jang, Byoung Kuk [12 ]
Yim, Hyung Joon [13 ]
Kim, Hyung Joon [14 ]
Lee, Byung Seok [15 ]
Kim, Bo Hyun
Kim, In Hee [16 ]
Cho, Eun-Young [17 ]
Lee, Jung Il [18 ]
Suh, Kyung-Suk [19 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Med, Seoul, South Korea
[3] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ Hosp, Liver Res Inst, Seoul, South Korea
[7] Univ Ulsan, Coll Med, Asan Med Ctr, Gastroenterol, Ulsan, South Korea
[8] Catholic Univ, Coll Med, Seoul, South Korea
[9] Korea Univ, Med Coll, Seoul, South Korea
[10] Korea Univ, Coll Med, Internal Med, Seoul, South Korea
[11] Soonchunhyang Univ, Med Coll, Internal Med, Asan, South Korea
[12] Keimyung Univ, Sch Med, Daegu, South Korea
[13] Korea Univ, Coll Med, Seoul, South Korea
[14] Chung Ang Univ, Coll Med, Seoul, South Korea
[15] Chungnam Natl Univ, Coll Med, Daejeon, South Korea
[16] Chonbuk Natl Univ, Jeonju, South Korea
[17] Wonkwang Univ, Coll Med, Iksan, South Korea
[18] Yonsei Univ, Coll Med, Seoul, South Korea
[19] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1511
引用
收藏
页码:861A / 862A
页数:2
相关论文
共 50 条
  • [41] Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study
    Dutta, Debnarayan
    Tatineni, Tushar
    Yarlagadda, Sreenija
    Gupte, Ajinkya
    Reddy, Sruthi K.
    Madhavan, Ram
    Nair, Haridas
    Sasidharan, Ajay
    Kannan, Rajesh
    Pottayil, Shibu G.
    Holla, Raghavendra
    Sudhindran, Surendran
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2021, 40 (04) : 389 - 401
  • [42] Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study
    Debnarayan Dutta
    Tushar Tatineni
    Sreenija Yarlagadda
    Ajinkya Gupte
    Sruthi K. Reddy
    Ram Madhavan
    Haridas Nair
    Ajay Sasidharan
    Rajesh Kannan
    Shibu G. Pottayil
    Raghavendra Holla
    Surendran Sudhindran
    Indian Journal of Gastroenterology, 2021, 40 : 389 - 401
  • [43] Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival
    Palavecino, Martin
    Chun, Yun S.
    Madoff, David C.
    Zorzi, Daria
    Kishi, Yoji
    Kaseb, Ahmed O.
    Curley, Steven A.
    Abdalla, Eddie R.
    Vauthey, Jean-Nicolas
    SURGERY, 2009, 145 (04) : 399 - 405
  • [44] Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma
    Yu, Jeong Il
    Yoon, Sang Min
    Park, Hee Chul
    Kim, Jong Hoon
    Kim, Tae Hyun
    Park, Joong-Won
    Seong, Jinsil
    Lee, Ik Jae
    Jang, Hong Seok
    Kay, Chul Seung
    Kim, Chul Yong
    Chie, Eui Kyu
    Kim, Jin Hee
    Kim, Mi-Sook
    Choi, Young Min
    CANCER RESEARCH AND TREATMENT, 2014, 46 (04): : 348 - 357
  • [45] Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
    Zhang, Lei
    Sun, Jun-Hui
    Hou, Zhong-Heng
    Zhong, Bin-Yan
    Yang, Min-Jie
    Zhou, Guan-Hui
    Wang, Wan-Sheng
    Huang, Peng
    Zhang, Shen
    Li, Zhi
    Zhu, Xiao-Li
    Yan, Zhi-Ping
    Ni, Cai-Fang
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (01) : 63 - 72
  • [46] Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
    Lei Zhang
    Jun-Hui Sun
    Zhong-Heng Hou
    Bin-Yan Zhong
    Min-Jie Yang
    Guan-Hui Zhou
    Wan-Sheng Wang
    Peng Huang
    Shen Zhang
    Zhi Li
    Xiao-Li Zhu
    Zhi-Ping Yan
    Cai-Fang Ni
    CardioVascular and Interventional Radiology, 2021, 44 : 63 - 72
  • [47] Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion: A Japanese nationwide survey
    Kokudo, Takashi
    Hasegawa, Kiyoshi
    Matsuyama, Yutaka
    Takayama, Tadatoshi
    Izumi, Namiki
    Kadoya, Masumi
    Kudo, Masatoshi
    Ku, Yonson
    Sakamoto, Michiie
    Nakashima, Osamu
    Kaneko, Shuichi
    Kokudo, Norihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study
    Nakano, Masahito
    Tanaka, Masatoshi
    Kuromatsu, Ryoko
    Nagamatsu, Hiroaki
    Satani, Manabu
    Niizeki, Takashi
    Okamura, Shusuke
    Iwamoto, Hideki
    Shimose, Shigeo
    Shirono, Tomotake
    Noda, Yu
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY, 2016, 64 : 651A - 651A
  • [49] Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study
    Nakano, Masahito
    Tanaka, Masatoshi
    Kuromatsu, Ryoko
    Nagamatsu, Hiroaki
    Satani, Manabu
    Niizeki, Takashi
    Okamura, Shusuke
    Iwamoto, Hideki
    Shimose, Shigeo
    Shirono, Tomotake
    Noda, Yu
    Koga, Hironori
    Torimura, Takuji
    ONCOTARGET, 2016, 7 (39) : 64400 - 64409
  • [50] Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
    Fan, Wenzhe
    Yuan, Guosheng
    Fan, Huishuang
    Li, Fuliang
    Wu, Yanqin
    Zhao, Yue
    Yao, Wang
    Wang, Yu
    Xue, Miao
    Yang, Jianyong
    Li, Jiaping
    CLINICAL THERAPEUTICS, 2019, 41 (08) : 1463 - 1476